{"id":"NCT01295710","sponsor":"Neovii Biotech","briefTitle":"Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)","officialTitle":"Phase 3 Study of US-ATG-F to Prevent Moderate to Severe Chronic GVHD in Adult Acute Myeloid Leukemia, Acute Lymphoid Leukemia, and Myelodysplastic Syndrome Patients After Allogeneic Stem Cell Transplantation From Unrelated Donors","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-10-10","primaryCompletion":"2015-10-15","completion":"2015-10-15","firstPosted":"2011-02-14","resultsPosted":"2019-03-20","lastUpdate":"2019-04-09"},"enrollment":260,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["GVHD","Adult Acute Myeloid Leukemia","Adult Acute Lymphoid Leukemia","Myelodysplastic Syndrome"],"interventions":[{"type":"BIOLOGICAL","name":"US-ATG-F","otherNames":["Anti-human-T-lymphocyte Immune Globulin, Rabbit"]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"US-ATG-F","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The study objective is to compare the efficacy and safety of US-ATG-F as a supplement to standard of care prophylaxis versus standard of care prophylaxis alone in moderate to severe chronic GVHD-free survival.","primaryOutcome":{"measure":"Number of Participants With First Occurrence of Moderate to Severe Chronic GVHD According to 2005 NIH Criteria as Determined by the Independent Endpoint Committee or Death From Any Cause After Allogeneic Stem Cell Transplantation","timeFrame":"Time from first study drug administration until the first occurrence of moderate to severe chronic GVHD according to 2005 NIH criteria as determined by the Independent Endpoint Committee, or death from any cause, assessed up to 48 months","effectByArm":[{"arm":"US-ATG-F","deltaMin":60,"sd":null},{"arm":"Placebo","deltaMin":72,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":28,"countries":["United States","Australia"]},"refs":{"pmids":["37341189"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":98,"n":126},"commonTop":["Nausea","Mucosal inflammation","Febrile neutropenia","Fatigue","Vomiting"]}}